busulfan has been researched along with Sterility, Male in 42 studies
Excerpt | Relevance | Reference |
---|---|---|
"Busulfan is an alkylating agent commonly used in cancer chemotherapy." | 7.01 | Mechanisms underlying impaired spermatogenic function in orchitis induced by busulfan. ( Dong, Z; Wang, D; Xu, S; Zhao, J; Zhao, L, 2023) |
" In rats, Busulfan administered in pregnancy can cause destruction of gonocytes and lack of spermatogenesis in adult male rats." | 3.65 | [Teratogenic damages of the male genital organs]. ( Krause, W, 1976) |
"Busulfan is an alkylating agent commonly used in cancer chemotherapy." | 3.01 | Mechanisms underlying impaired spermatogenic function in orchitis induced by busulfan. ( Dong, Z; Wang, D; Xu, S; Zhao, J; Zhao, L, 2023) |
"Male infertility is a global concern, with a noticeable increase in the decline of spermatogenesis and sperm quality." | 1.91 | Puerarin improves busulfan-induced disruption of spermatogenesis by inhibiting MAPK pathways. ( Chen, TX; Chen, XQ; Li, HT; Song, J; Xia, YF; Zeng, XH; Zhao, W; Zhong, K, 2023) |
" Loboob at a dosage of 140mg/kg improved sperm viability." | 1.72 | Preserving effect of Loboob (a traditional multi-herbal formulation) on sperm parameters of male rats with busulfan-induced subfertility. ( Badr, P; Bahmanpour, S; Dabbaghmanesh, MH; Jahromi, BN; Keshavarz, M; Koohpeyma, F; Najib, FS; Namazi, N; Noori, A; Poordast, T; Zare, N, 2022) |
"Busulfan (BSU) is a chemotherapeutic drug that can cause subfertility or sterility in males." | 1.72 | Impaired spermatogenesis caused by busulfan is partially ameliorated by treatment with conditioned medium of adipose tissue derived mesenchymal stem cells. ( Abbaszadeh, HA; Abdi, S; Abdollahifar, MA; Aliaghaei, A; Azad, N; Ebrahimi, V; Fadaei Fathabadi, F; Faraji Sani, M; Ghanimat, F; Movahedi, M; Raoofi, A, 2022) |
"Molybdenum (Mo) plays an important role in maintaining normal metabolism." | 1.51 | Effect of molybdenum on reproductive function of male mice treated with busulfan. ( Dong, WY; Liu, FJ; Shi, XH; Zhang, YL; Zhao, H, 2019) |
"Busulfan is a widely used chemotherapeutic drug for chronic myelogenous leukemia and bone marrow transplantation." | 1.51 | Melatonin protects spermatogonia from the stress of chemotherapy and oxidation via eliminating reactive oxidative species. ( Lin, Z; Mi, J; Song, H; Sun, Z; Wei, R; Xia, Q; Yang, Y; Zhang, X; Zou, K, 2019) |
"Busulfan is a chemotherapy drug that has side effects on spermatogonial stem cells (SSC)." | 1.43 | Gonadotoxic effects of busulfan in two strains of mice. ( Bordignon, V; Chemeris, RO; Comim, FV; Glanzner, WG; Gonçalves, PB; Gutierrez, K; Rigo, ML, 2016) |
" Our study indicated that intratesticular injection busulfan for the preparation of recipients in mice is safe and feasible." | 1.43 | Testicular Busulfan Injection in Mice to Prepare Recipients for Spermatogonial Stem Cell Transplantation Is Safe and Non-Toxic. ( Chen, X; Hao, H; He, Y; Liang, M; Liu, L; Qin, T; Qin, Y; Wang, C; Wang, D; Zhao, X, 2016) |
"Busulfan was used to induce testicular failure in 3-week-old immature FVB/NJNarl wild-type recipient mice." | 1.38 | Bioluminescence imaging as a tool to evaluate germ cells in vitro and transplantation in vivo as fertility preservation of prepubertal male mice. ( Chen, CH; Hsu, MI; Huang, YH; Lai, WF; Tzeng, CR; Wang, CW, 2012) |
"Busulfan treatment caused acute declines in testis volume and sperm counts, indicating a disruption of spermatogenesis." | 1.34 | Characterization, cryopreservation, and ablation of spermatogonial stem cells in adult rhesus macaques. ( Hermann, BP; Hobbs, RM; Lin, CC; McFarland, D; Orwig, KE; Pandolfi, PP; Rodriguez, M; Schatten, GP; Sheng, Y; Shuttleworth, JJ; Sukhwani, M; Tomko, J, 2007) |
" However, because the steepness of the dose-response curves indicates that direct administration of busulfan is not ideal for this purpose, 15 mg busulfan kg(-1) was administered to pregnant females at various times between day 10." | 1.32 | Dose-response of RAG2-/-/gammac-/- mice to busulfan in preparation for spermatogonial transplantation. ( Betteridge, KJ; Foster, RA; Hahnel, AC; Moisan, AE, 2003) |
" Azoospermia at 56 days after treatment, which is a result of stem cell killing, was achieved at doses of over 30 mg/kg; this dose is below the LD50 for animal survival, which was over 40 mg/kg." | 1.27 | Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations. ( Bucci, LR; Meistrich, ML, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (21.43) | 18.7374 |
1990's | 2 (4.76) | 18.2507 |
2000's | 8 (19.05) | 29.6817 |
2010's | 17 (40.48) | 24.3611 |
2020's | 6 (14.29) | 2.80 |
Authors | Studies |
---|---|
Jiang, S | 1 |
Xu, Y | 1 |
Fan, Y | 1 |
Hu, Y | 2 |
Zhang, Q | 1 |
Su, W | 1 |
Bahmanpour, S | 1 |
Keshavarz, M | 1 |
Koohpeyma, F | 1 |
Badr, P | 1 |
Noori, A | 1 |
Dabbaghmanesh, MH | 1 |
Poordast, T | 1 |
Najib, FS | 1 |
Zare, N | 1 |
Namazi, N | 1 |
Jahromi, BN | 1 |
Zhao, L | 1 |
Zhao, J | 1 |
Dong, Z | 1 |
Xu, S | 1 |
Wang, D | 2 |
Li, HT | 1 |
Zhong, K | 1 |
Xia, YF | 1 |
Song, J | 1 |
Chen, XQ | 1 |
Zhao, W | 1 |
Zeng, XH | 1 |
Chen, TX | 1 |
Yu, S | 1 |
Zhao, Y | 1 |
Zhang, FL | 1 |
Li, YQ | 1 |
Shen, W | 1 |
Sun, ZY | 1 |
Abdollahifar, MA | 1 |
Azad, N | 1 |
Faraji Sani, M | 1 |
Raoofi, A | 1 |
Abdi, S | 1 |
Aliaghaei, A | 1 |
Abbaszadeh, HA | 1 |
Ebrahimi, V | 1 |
Fadaei Fathabadi, F | 1 |
Ghanimat, F | 1 |
Movahedi, M | 1 |
Kang, Z | 1 |
Qiao, N | 1 |
Tan, Z | 1 |
Tang, Z | 1 |
Li, Y | 1 |
Dehghani, F | 1 |
Sotoude, N | 1 |
Bordbar, H | 1 |
Panjeshahin, MR | 1 |
Karbalay-Doust, S | 1 |
Kadam, P | 1 |
Ntemou, E | 1 |
Baert, Y | 2 |
Van Laere, S | 1 |
Van Saen, D | 2 |
Goossens, E | 2 |
AbuMadighem, A | 1 |
Solomon, R | 1 |
Stepanovsky, A | 1 |
Kapelushnik, J | 1 |
Shi, Q | 1 |
Meese, E | 1 |
Lunenfeld, E | 1 |
Huleihel, M | 1 |
Liu, FJ | 1 |
Dong, WY | 1 |
Zhao, H | 1 |
Shi, XH | 1 |
Zhang, YL | 1 |
Liu, Y | 1 |
Wu, X | 1 |
Jiang, H | 1 |
Zhang, X | 2 |
Xia, Q | 1 |
Wei, R | 1 |
Song, H | 1 |
Mi, J | 1 |
Lin, Z | 1 |
Yang, Y | 1 |
Sun, Z | 1 |
Zou, K | 1 |
Cai, YT | 1 |
Xiong, CL | 1 |
Shen, SL | 1 |
Rao, JP | 1 |
Liu, TS | 1 |
Qiu, F | 1 |
Wilhelmsson, M | 1 |
Vatanen, A | 1 |
Borgström, B | 1 |
Gustafsson, B | 1 |
Taskinen, M | 1 |
Saarinen-Pihkala, UM | 1 |
Winiarski, J | 1 |
Jahnukainen, K | 1 |
Benavides-Garcia, R | 1 |
Joachim, R | 1 |
Pina, NA | 1 |
Mutoji, KN | 1 |
Reilly, MA | 1 |
Hermann, BP | 2 |
Gutierrez, K | 1 |
Glanzner, WG | 1 |
Chemeris, RO | 1 |
Rigo, ML | 1 |
Comim, FV | 1 |
Bordignon, V | 1 |
Gonçalves, PB | 1 |
Qin, Y | 1 |
Liu, L | 1 |
He, Y | 1 |
Wang, C | 1 |
Liang, M | 1 |
Chen, X | 1 |
Hao, H | 1 |
Qin, T | 1 |
Zhao, X | 1 |
Hirabayashi, M | 1 |
Yoshizawa, Y | 1 |
Kato, M | 1 |
Tsuchiya, T | 1 |
Nagao, S | 1 |
Hochi, S | 1 |
Yuan, Z | 1 |
Hou, R | 1 |
Wu, J | 1 |
Zohni, K | 1 |
Tan, SL | 1 |
Chan, P | 1 |
Nagano, MC | 1 |
Ning, L | 1 |
in't Veld, P | 1 |
Tournaye, H | 1 |
Chen, CH | 1 |
Wang, CW | 1 |
Hsu, MI | 1 |
Huang, YH | 1 |
Lai, WF | 1 |
Tzeng, CR | 1 |
Koruji, M | 1 |
Shahverdi, A | 1 |
Janan, A | 1 |
Piryaei, A | 1 |
Lakpour, MR | 1 |
Gilani Sedighi, MA | 1 |
Niu, Z | 1 |
Chu, Z | 1 |
Yu, M | 1 |
Bai, Y | 1 |
Wang, L | 1 |
Hua, J | 1 |
Shinohara, T | 1 |
Orwig, KE | 3 |
Avarbock, MR | 2 |
Brinster, RL | 3 |
Brinster, CJ | 1 |
Ryu, BY | 1 |
Karagenc, L | 1 |
Moisan, AE | 1 |
Foster, RA | 1 |
Betteridge, KJ | 1 |
Hahnel, AC | 1 |
Udagawa, K | 1 |
Ogawa, T | 1 |
Watanabe, T | 1 |
Tamura, Y | 1 |
Kita, K | 1 |
Kubota, Y | 1 |
Sukhwani, M | 1 |
Lin, CC | 1 |
Sheng, Y | 1 |
Tomko, J | 1 |
Rodriguez, M | 1 |
Shuttleworth, JJ | 1 |
McFarland, D | 1 |
Hobbs, RM | 1 |
Pandolfi, PP | 1 |
Schatten, GP | 1 |
Wang, X | 1 |
Ding, Q | 1 |
Zhang, Y | 1 |
Wang, H | 1 |
Ma, L | 1 |
Xie, X | 1 |
Zimmermann, JW | 1 |
Krause, W | 1 |
Schein, PS | 1 |
Winokur, SH | 1 |
Bousquet, J | 1 |
Vanhems, E | 1 |
Dubuisson, L | 1 |
Boujrad, N | 1 |
Guillaumin, JM | 1 |
Bardos, P | 1 |
Hochereau de Reviers, MT | 1 |
Drosdowsky, MA | 1 |
Carreau, S | 1 |
Bucci, LR | 1 |
Meistrich, ML | 1 |
Hilscher, W | 1 |
Jones, P | 1 |
Jackson, H | 3 |
Craig, AW | 1 |
Eberle, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effects of Intratesticular PRP Injection[NCT04237779] | 200 participants (Actual) | Interventional | 2020-01-27 | Completed | |||
Filgrastim for Treatment of Premature Ovarian Insufficiency: Randomized Clinical Trial[NCT02783937] | Phase 4 | 10 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 reviews available for busulfan and Sterility, Male
Article | Year |
---|---|
Mechanisms underlying impaired spermatogenic function in orchitis induced by busulfan.
Topics: Busulfan; Humans; Infertility, Male; Male; Orchitis; Spermatogonia; Testis | 2023 |
Immunosuppressive and cytotoxic chemotherapy: long-term complications.
Topics: Alkylating Agents; Antineoplastic Agents; Azathioprine; Bleomycin; Busulfan; Carcinogens; Chemical a | 1975 |
["Environment and fertility". A contribution to the sensitivity of male germ cells to environmental pollutants].
Topics: Animals; Busulfan; Cell Division; Environmental Pollutants; Germ Cells; Gestational Age; Humans; Inf | 1985 |
Effects of alkylating chemicals on reproductive cells.
Topics: Alkylating Agents; Animals; Anthracenes; Autoradiography; Azirines; Busulfan; Esters; Female; Fertil | 1969 |
Antispermatogenic agents.
Topics: Alkylating Agents; Animals; Antimetabolites; Busulfan; Chemosterilants; Contraceptive Agents; Cricet | 1970 |
37 other studies available for busulfan and Sterility, Male
Article | Year |
---|---|
Busulfan impairs blood-testis barrier and spermatogenesis by increasing noncollagenous 1 domain peptide via matrix metalloproteinase 9.
Topics: Animals; Antineoplastic Agents, Alkylating; Autoantigens; Blood-Testis Barrier; Busulfan; Cell Membr | 2022 |
Preserving effect of Loboob (a traditional multi-herbal formulation) on sperm parameters of male rats with busulfan-induced subfertility.
Topics: Animals; Busulfan; Humans; Infertility, Male; Male; Rats; Semen; Sperm Count; Sperm Motility; Sperma | 2022 |
Puerarin improves busulfan-induced disruption of spermatogenesis by inhibiting MAPK pathways.
Topics: Animals; Busulfan; Humans; Infertility, Male; Male; Mice; Semen; Spermatogenesis; Testis | 2023 |
Chestnut polysaccharides benefit spermatogenesis through improvement in the expression of important genes.
Topics: Animals; Busulfan; Disease Models, Animal; Drugs, Chinese Herbal; Fagaceae; Gene Expression Regulati | 2020 |
Impaired spermatogenesis caused by busulfan is partially ameliorated by treatment with conditioned medium of adipose tissue derived mesenchymal stem cells.
Topics: Animals; Busulfan; Culture Media, Conditioned; Infertility, Male; Male; Mesenchymal Stem Cells; Mice | 2022 |
Expression patterns and changes of the LCN2 gene in the testes of induced cryptorchidism and busulfan-treated mice.
Topics: Aging; Animals; Busulfan; Cryptorchidism; Gene Expression; In Situ Hybridization; Infertility, Male; | 2017 |
The use of platelet-rich plasma (PRP) to improve structural impairment of rat testis induced by busulfan.
Topics: Animals; Busulfan; Cell Differentiation; Infertility, Male; Male; Platelet-Rich Plasma; Rats; Rats, | 2019 |
Co-transplantation of mesenchymal stem cells improves spermatogonial stem cell transplantation efficiency in mice.
Topics: Adult Germline Stem Cells; Animals; Busulfan; Cadmium Chloride; Cell Survival; Disease Models, Anima | 2018 |
Development of Spermatogenesis In Vitro in Three-Dimensional Culture from Spermatogonial Cells of Busulfan-Treated Immature Mice.
Topics: Animals; Busulfan; Cell Differentiation; Cells, Cultured; DEAD-box RNA Helicases; DNA-Binding Protei | 2018 |
Effect of molybdenum on reproductive function of male mice treated with busulfan.
Topics: Animals; Apoptosis; Busulfan; Gonadal Steroid Hormones; Infertility, Male; Male; Mice; Molybdenum; O | 2019 |
Raman spectroscopic analysis of testicular lamina propria predicts spermatogenesis in a mouse infertility model.
Topics: Animals; Busulfan; Disease Models, Animal; Infertility, Male; Male; Mice; Mucous Membrane; Seminifer | 2019 |
Melatonin protects spermatogonia from the stress of chemotherapy and oxidation via eliminating reactive oxidative species.
Topics: Animals; Antineoplastic Agents, Alkylating; Antioxidants; Apoptosis; Busulfan; Cells, Cultured; Drug | 2019 |
Mesenchymal stem cell-secreted factors delayed spermatogenesis injuries induced by busulfan involving intercellular adhesion molecule regulation.
Topics: Animals; Apoptosis; Blood-Testis Barrier; Busulfan; Cadherins; Cell Adhesion; Culture Media, Conditi | 2019 |
Adult testicular volume predicts spermatogenetic recovery after allogeneic HSCT in childhood and adolescence.
Topics: Adolescent; Allografts; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Pres | 2014 |
Granulocyte colony-stimulating factor prevents loss of spermatogenesis after sterilizing busulfan chemotherapy.
Topics: Animals; Antineoplastic Agents, Alkylating; Busulfan; Dose-Response Relationship, Drug; Drug Interac | 2015 |
Gonadotoxic effects of busulfan in two strains of mice.
Topics: Animals; Antineoplastic Agents, Alkylating; Busulfan; Cell Shape; Female; Fertility; Gene Expression | 2016 |
Testicular Busulfan Injection in Mice to Prepare Recipients for Spermatogonial Stem Cell Transplantation Is Safe and Non-Toxic.
Topics: Adult Stem Cells; Animals; Busulfan; Female; Fertility; Immunosuppressive Agents; Infertility, Male; | 2016 |
Availability of subfertile transgenic rats expressing the c-myc gene as recipients for spermatogonial transplantation.
Topics: Animals; Busulfan; Cell Differentiation; Fluorescent Antibody Technique; Genes, myc; Green Fluoresce | 2009 |
Generation of mice by transplantation of an adult spermatogonial cell line after cryopreservation.
Topics: Animals; Animals, Newborn; Busulfan; Cell Line; Cell Proliferation; Cryopreservation; Female; Hair C | 2009 |
The efficiency of male fertility restoration is dependent on the recovery kinetics of spermatogonial stem cells after cytotoxic treatment with busulfan in mice.
Topics: Animals; Busulfan; Cytotoxins; Dose-Response Relationship, Drug; Infertility, Male; Kinetics; Male; | 2012 |
Orthotopic grafting of cryopreserved prepubertal testicular tissue: in search of a simple yet effective cryopreservation protocol.
Topics: Animals; Busulfan; Cryopreservation; Disease Models, Animal; Fertility Preservation; Graft Survival; | 2012 |
Bioluminescence imaging as a tool to evaluate germ cells in vitro and transplantation in vivo as fertility preservation of prepubertal male mice.
Topics: Animals; Benzothiazoles; Busulfan; Disease Models, Animal; Feasibility Studies; Female; Fertility Pr | 2012 |
Proliferation of small number of human spermatogonial stem cells obtained from azoospermic patients.
Topics: Analysis of Variance; Animals; Azoospermia; Biomarkers; Biopsy; Busulfan; Cell Count; Cell Culture T | 2012 |
Germ-like cell differentiation from induced pluripotent stem cells (iPSCs).
Topics: Animals; Busulfan; Cell Culture Techniques; Cell Differentiation; Cells, Cultured; Culture Media; Em | 2013 |
Restoration of spermatogenesis in infertile mice by Sertoli cell transplantation.
Topics: Animals; Busulfan; Cadmium; Histocytochemistry; Immunosuppressive Agents; Infertility, Male; Male; M | 2003 |
Restoration of fertility by germ cell transplantation requires effective recipient preparation.
Topics: Alkylating Agents; Animals; Busulfan; Female; Fertility; Germ Cells; Haplotypes; Infertility, Male; | 2003 |
Dose-response of RAG2-/-/gammac-/- mice to busulfan in preparation for spermatogonial transplantation.
Topics: Alkylating Agents; Animals; Busulfan; Cell Death; DNA-Binding Proteins; Dose-Response Relationship, | 2003 |
Testosterone administration promotes regeneration of chemically impaired spermatogenesis in rats.
Topics: Animals; Busulfan; Contraindications; Gonadotropin-Releasing Hormone; Infertility, Male; Male; Rats; | 2006 |
Characterization, cryopreservation, and ablation of spermatogonial stem cells in adult rhesus macaques.
Topics: Animals; Antineoplastic Agents, Alkylating; Busulfan; Cryopreservation; Dose-Response Relationship, | 2007 |
Two allogeneic descendents derived from the high-dose busulfan-treated infertile mouse model after freeze-thawed spermatogonial stem cell transplantation.
Topics: Animals; Busulfan; Cell Differentiation; Cell Proliferation; Cell Survival; Cryopreservation; Female | 2008 |
Spermatogenesis following male germ-cell transplantation.
Topics: Animals; Busulfan; Infertility, Male; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Microinj | 1994 |
[Teratogenic damages of the male genital organs].
Topics: Abnormalities, Drug-Induced; Adult; Busulfan; Cryptorchidism; Cyproterone; Female; Genitalia, Male; | 1976 |
[Ultrastructure of testicular Sertoli cells in normal and dysgenesic rats, during the fetal and postnatal periods].
Topics: Animals; Animals, Newborn; Busulfan; Fetus; Infertility, Male; Male; Microscopy, Electron; Rats; Ser | 1978 |
Germ cell-Sertoli cell interactions and production of testosterone by purified Leydig cells from mature rat.
Topics: Animals; Busulfan; Cell Communication; Cells, Cultured; Cryptorchidism; Follicle Stimulating Hormone | 1992 |
Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations.
Topics: Alkylating Agents; Animals; Busulfan; Cell Differentiation; Cell Survival; DNA; DNA Damage; Fertilit | 1987 |
Estimation of the duration of spermatogenesis in japanese quail, Coturnix coturnix japonica, using antispermatogonial chemicals.
Topics: Alkanesulfonates; Animals; Busulfan; Coturnix; Cyclohexanols; Infertility, Male; Male; Spermatogenes | 1972 |
[Myleran and damage to spermatozoa in man].
Topics: Adult; Busulfan; Humans; Infertility, Male; Male; Primary Myelofibrosis; Spermatozoa | 1969 |